A wide range of drugs can produce hallucinations and paranoia, from illegal substances like methamphetamine and LSD to perfectly legal prescription medications like corticosteroids and even sleep aids. The specific type of hallucination and the flavor of paranoia vary depending on which brain systems a drug activates or disrupts, but the list of potential culprits is longer than most people expect. Some drugs reliably cause perceptual distortions at ordinary doses, while others trigger psychotic symptoms only at high doses, during withdrawal, or in people with a particular genetic makeup.
Classic Psychedelics and the Serotonin System
LSD, psilocybin (the active compound in “magic mushrooms”), mescaline, and DMT are the textbook hallucinogens. They produce vivid visual distortions, altered sense of time, synesthesia, and sometimes full-blown hallucinations by binding to a specific serotonin receptor in the brain. There is now broad scientific consensus that this receptor, known as 5-HT2A, is the primary target responsible for hallucinogenesis. Research has shown that the intensity of someone’s subjective experience on psilocybin correlates with how many of these receptors the drug occupies.1PubMed Central. Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison
Paranoia on classic psychedelics is less predictable than hallucinations. It tends to emerge during “bad trips” rather than being a reliable pharmacological effect. Set and setting matter enormously: someone who takes psilocybin in a calm, supervised environment is far less likely to become paranoid than someone who takes the same dose in an unfamiliar or threatening situation. That said, at high enough doses, even experienced users can develop transient paranoid ideation, particularly with LSD, which lasts many hours and leaves little room for escape if the experience turns frightening.
Stimulants and Dopamine-Driven Paranoia
If classic psychedelics are the prototypical hallucinogens, stimulants are the prototypical paranoia drugs. Methamphetamine, cocaine, and amphetamines all flood the brain with dopamine, and at high doses or after prolonged use, this dopamine surge can produce intense suspicion, paranoid delusions, and even hallucinations. Paranoid delusions during stimulant use can involve irrational beliefs of being watched, followed, or targeted.2PubMed Central. Understanding the Mechanisms of Action and Effects of Drugs of Abuse
Stimulant-induced paranoia can look virtually identical to paranoid schizophrenia. Someone on a methamphetamine binge might become convinced that neighbors are spying through the walls, that tracking devices have been planted in their car, or that strangers on the street are undercover agents. These beliefs feel absolutely real to the person experiencing them. Hallucinations tend to be auditory (hearing voices or sounds that are not there) or tactile (the sensation of bugs crawling under the skin, sometimes called “meth mites”), though visual hallucinations also occur. Sleep deprivation during a multi-day stimulant binge compounds the problem, since going without sleep for long periods can trigger hallucinations on its own.
Research into why dopamine overactivity creates paranoid thinking points to a phenomenon called aberrant salience. Essentially, the brain starts assigning enormous importance to random environmental details, meaningless coincidences, or neutral interactions, weaving them into a narrative of threat. Experimental work has found that manipulating salience and dopamine activity produces changes in “magical thinking,” the tendency to draw causal connections where none exist, which is consistent with this model of delusion formation.3Journal of Experimental Psychopathology. An Experimental Examination of the Aberrant Salience Hypothesis Using a Salience Manipulation and a Behavioral Magical Thinking Task
Cannabis and Synthetic Cannabinoids
Natural cannabis can trigger paranoia even in casual users, particularly with high-THC strains. Most people who have smoked marijuana know someone who “got paranoid” after a few too many puffs. At lower doses this is usually a transient and relatively mild anxiety. At higher doses, or in vulnerable individuals, cannabis can produce genuine psychotic symptoms including hallucinations, delusions, and disorganized thinking.
Synthetic cannabinoids, sold under street names like “Spice” or “K2,” are far more dangerous in this regard. These lab-made chemicals bind to the same brain receptors as THC but often with much greater potency and far less predictability. Psychosis is a common adverse outcome of synthetic cannabinoid use, and clinicians are advised to consider it in the differential diagnosis when a patient presents with sudden-onset psychotic symptoms.4PubMed Central. Synthetic Cannabinoids-“Spice” Can Induce a Psychosis: A Brief Review The gap between synthetic cannabinoids and natural cannabis in terms of psychosis risk is substantial; synthetic versions have been linked to prolonged psychotic episodes lasting days or even weeks.
Genetics plays a real role in who gets paranoid from cannabis and who does not. A systematic review of genetic research found that polymorphisms in genes involved in dopamine pathways are consistently linked to cannabis-induced psychosis. The most robust finding involves a gene called COMT: people who carry a specific variant (the Val allele at a particular location) face a higher risk of psychotic reactions to cannabis.5PubMed. Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms This helps explain why two people can smoke the same joint and have completely different experiences, one relaxed and the other deeply paranoid.
Dissociative Drugs
Ketamine, PCP (phencyclidine), and DXM (dextromethorphan, the cough suppressant) all work by blocking a type of brain receptor called NMDA. This produces a distinctive dissociative state where people feel detached from their body, their surroundings, or both. At higher doses, these drugs can cause full hallucinations and paranoia that closely mimic schizophrenia. In controlled research, even subanesthetic doses of ketamine given to healthy volunteers produced dose-dependent increases in both positive psychotic symptoms (hallucinations, delusions) and negative symptoms (emotional flatness, social withdrawal).6PubMed. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis
PCP deserves special mention because it has a well-earned reputation for producing aggressive, unpredictable psychotic behavior. Unlike ketamine, which tends to immobilize users at high doses, PCP can leave people mobile, confused, and combative while simultaneously hallucinating. PCP psychosis can persist for days after the drug has been metabolized, and people with a history of PCP use sometimes develop chronic psychotic symptoms that outlast their drug use.
Salvinorin A, the active compound in the plant Salvia divinorum, works through a completely different mechanism than other dissociatives. It acts on kappa-opioid receptors rather than NMDA receptors, yet it produces intense hallucinations and a powerful sense of disconnection from reality.7PubMed Central. Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders Users often describe being transported to entirely different realities, losing awareness of their physical environment completely. In human studies, salvinorin A produced perceptual and cognitive effects resembling those of classic psychedelics but with an intense somatic and dissociative component that sets it apart.8PubMed Central. Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans Paranoia is less characteristic of salvia than raw perceptual chaos, but panic and fear are common, especially because the onset is extremely rapid (seconds when smoked) and the experience can feel utterly uncontrollable.
Synthetic Cathinones
Synthetic cathinones, commonly known as “bath salts,” are stimulant drugs that mimic the effects of cathinone, a natural compound found in the khat plant. They made headlines in the early 2010s for producing extreme psychotic behavior, and the clinical literature supports those reports. These drugs activate both serotonin and dopamine systems, which may explain why they produce a combination of stimulant-type paranoia and hallucinatory experiences that is particularly severe.9PubMed Central. Synthetic cathinones (“bath salts”)
Repeated use of synthetic cathinones is associated with a paranoid hallucinatory delirium. A subset of users develops what clinicians call “excited delirium,” a dangerous syndrome of extreme agitation, paranoia, and violent behavior that can be life-threatening.10PubMed. Excited delirium following use of synthetic cathinones (bath salts) These episodes are especially dangerous because the person may have superhuman-seeming strength and pain tolerance while being completely unable to distinguish reality from hallucination.
Prescription Medications You Might Not Suspect
Illicit drugs get the most attention, but several classes of prescription medication can also produce hallucinations and paranoia. These side effects often blindside patients and their families because the drugs are taken for entirely unrelated conditions.
Corticosteroids
Prednisone, dexamethasone, and other corticosteroids prescribed for inflammation, autoimmune conditions, and allergic reactions can cause a full spectrum of psychiatric symptoms, from euphoria and insomnia to frank psychosis with hallucinations and paranoid delusions. Steroid-induced psychosis is well-documented and more common at higher doses, though case reports exist of psychosis triggered even by local steroid injections.11PubMed Central. Steroid-induced psychosis One published case described a 35-year-old man with no psychiatric history who developed a psychotic episode after a single injection of dexamethasone. The risk is dose-dependent: short courses at low doses rarely cause problems, but high-dose regimens lasting more than a few days carry meaningful psychiatric risk.
Dopaminergic Medications for Parkinson’s Disease
Levodopa and dopamine agonists used to treat Parkinson’s disease have long been associated with visual hallucinations and psychosis, though the relationship is more complex than simple cause and effect. While dopaminergic medications have been linked to Parkinson’s disease psychosis, a clear causal link has not been definitively established. Other neurotransmitter systems, particularly those involving noradrenaline, serotonin, and acetylcholine, also appear to play important roles.12The Journal of Neuropsychiatry and Clinical Neurosciences. Visual Hallucinations and the Role of Medications in Parkinson’s Disease: Triggers, Pathophysiology, and Management The hallucinations typically begin as benign “passage hallucinations” (brief impressions of something moving in peripheral vision) and can progress to fully formed visual hallucinations of people or animals. Paranoia may develop alongside these hallucinations, especially as the disease and its treatment advance.
Sleep Medications
Zolpidem (Ambien) and related sedative-hypnotic drugs prescribed for insomnia can produce hallucinations, sometimes striking and vivid. Case reports describe patients experiencing prolonged visual hallucinations after taking zolpidem, and there is evidence that combining zolpidem with certain antidepressants may increase this risk.13PubMed. Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction The hallucinations sometimes occur in a twilight state where the person is not fully asleep but not fully awake either, leading to complex behaviors the person may not remember the next day.14PubMed Central. Zolpidem-induced Hallucinations: A Brief Case Report from the Indian Subcontinent
Antimalarial Drugs
Mefloquine, a medication used to prevent and treat malaria, has been linked to rare but severe neuropsychiatric reactions including anxiety, depression, hallucinations, and psychosis with paranoid delusions. One published case described a 37-year-old man who developed frank psychosis with psychomotor agitation and paranoid delusions one week after receiving a therapeutic dose of mefloquine.15PubMed Central. Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report Military personnel have been disproportionately affected because mefloquine was widely used as a prophylactic for troops deployed to malaria-endemic regions. The drug has largely been replaced by alternatives with better psychiatric safety profiles, but it remains available and in use in some settings.
Alcohol and Sedative Withdrawal
It is not always the drug itself that causes hallucinations and paranoia. Sometimes stopping a drug does. The most dangerous example is alcohol withdrawal. Someone who has been drinking heavily for a prolonged period and abruptly stops can develop delirium tremens (DT), which sits at the most severe end of the alcohol withdrawal spectrum and can be fatal without medical treatment. DT presents with a combination of severe withdrawal symptoms and delirium that often includes hallucinations and agitation.16PubMed Central. Delirium Tremens: Assessment and Management The hallucinations are classically visual and often terrifying: insects, snakes, or threatening figures. Paranoia accompanies the confusion and disorientation.
Benzodiazepine withdrawal can produce a nearly identical syndrome. Someone who has taken high doses of alprazolam, clonazepam, or diazepam daily for months and suddenly stops may experience seizures, hallucinations, and psychosis. Both alcohol and benzodiazepines work through the same neurotransmitter system (GABA), and abrupt removal of either throws the brain into a state of dangerous hyperexcitability. This is why medical detox programs taper these substances gradually rather than stopping them cold.
Ergot and Historical Poisoning
Long before LSD was synthesized in a lab, people were experiencing hallucinations from ergot, a fungus that infects rye and other grains. Ergot alkaloids, the toxic compounds produced by the Claviceps genus, caused devastating epidemics throughout history and have been implicated in episodes of mass hallucination that were sometimes attributed to witchcraft or demonic possession.17PubMed Central. Ergot: from witchcraft to biotechnology Albert Hofmann derived LSD from ergot alkaloids in 1938, so there is a direct chemical lineage between medieval grain poisoning and the psychedelic revolution of the 1960s. Ergot alkaloids are also the basis for several pharmaceutical drugs, including ergotamine for migraines. The connection is a useful reminder that many hallucinogenic compounds exist on a continuum with legitimate medications.
When Drug-Induced Psychosis Does Not Go Away
For most people, hallucinations and paranoia triggered by drugs resolve once the drug leaves the system, or after a brief period of treatment. But for a significant minority, a drug-induced psychotic episode is the first sign of a longer-term psychiatric illness. Large-scale studies have tracked thousands of patients after an initial substance-induced psychosis and found that roughly a quarter to a third go on to develop schizophrenia or bipolar disorder.
One large study found that about 32% of patients with substance-induced psychosis eventually converted to either schizophrenia-spectrum or bipolar disorders. The conversion rate was highest for cannabis-induced psychosis, with about 47% eventually receiving one of those diagnoses. Half the conversions to schizophrenia happened within about three years of the initial psychotic episode.18PubMed. Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis A separate meta-analysis put the overall transition rate to schizophrenia specifically at about 25%.19Schizophrenia Bulletin. Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis
A more recent study examining six-year outcomes found that the cumulative transition rate from substance-induced psychosis to schizophrenia-spectrum disorders was about 28%, while the transition rate to bipolar disorder was much lower at roughly 5%. Younger men, those with cannabis-induced psychosis, and those with repeated emergency admissions for psychotic episodes were at the highest risk of developing schizophrenia-spectrum disorders.20PubMed. Transition From Substance-Induced Psychosis to Schizophrenia Spectrum Disorder or Bipolar Disorder These findings do not mean that drugs “cause” schizophrenia in a straightforward sense. The prevailing interpretation is that substance use can unmask or accelerate an illness that was already developing, particularly in people with genetic vulnerability. But the practical implication is clear: a drug-induced psychotic episode should be taken seriously as a potential warning sign, not dismissed as a one-off bad reaction.
How Emergency Departments Respond
When someone arrives at an emergency room in acute drug-induced psychosis, the immediate goal is to ensure safety and reduce agitation. A scoping review of clinical guidelines found that benzodiazepines (such as diazepam, lorazepam, and midazolam) and antipsychotics (such as olanzapine and droperidol) are the mainstays of treatment across international guidelines.21PubMed Central. Guidelines and treatment for illicit drug related presentations in emergency departments: A scoping review The choice between these depends partly on what the person took. Benzodiazepines are generally preferred for stimulant-induced psychosis because they calm the central nervous system without the risk of certain side effects that antipsychotics carry. For psychosis triggered by other drugs, antipsychotics may be used alone or in combination with a benzodiazepine.
The trickiest part of emergency management is often figuring out what the person actually took. Street drugs are frequently contaminated or mislabeled, synthetic cannabinoids and cathinones come in unpredictable formulations, and patients in psychosis are rarely able to give a reliable history. Urine drug screens help but have gaps: many synthetic drugs do not show up on standard panels. Clinicians often have to treat the symptoms in front of them while waiting for the pharmacology to declare itself through the patient’s clinical course.
Why the Same Drug Affects People So Differently
One of the most frustrating aspects of drug-induced hallucinations and paranoia is how unpredictable they can be. Two people take the same substance at the same dose, and one has a mild experience while the other ends up in a psychiatric emergency. Several factors explain this variability. Genetic differences in dopamine metabolism, as seen with the COMT gene variants and cannabis psychosis, are one piece.5PubMed. Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms Family history of psychotic illness is another strong predictor: someone with a first-degree relative who has schizophrenia is at much higher risk of developing psychotic symptoms from drug use.
Sleep deprivation, stress, concurrent use of multiple substances, and pre-existing mental health conditions all lower the threshold. Age matters too: adolescents and young adults appear more vulnerable to drug-induced psychosis than older adults, likely because the brain is still developing and the neural circuits involved in reality-testing are not yet fully mature. Dose and route of administration also play obvious roles. Smoking or injecting a drug delivers it to the brain faster than swallowing it, producing a sharper spike in neurotransmitter levels and a higher risk of acute psychotic reactions. None of these factors is destiny on its own, but they stack. The more risk factors someone carries, the narrower the margin between a recreational experience and a psychiatric crisis.